With selection of its first three research projects, the new UC San Diego-Roche Extending Innovation Network program has been launched, according to a Monday release.
The program aims to accelerate the discovery of new drug therapies through research.
Under this partnership, faculty-initiated research projects are selected for funding from proposals solicited campus-wide on a planned biannual basis.
The program is headed by a joint-steering committee composed of two Roche researchers and two UCSD faculty members.
“We are very pleased about this exciting and innovative partnership, which strengthens UCSD Health Sciences’ strategic goal of broadly advancing our programs in drug discovery,” said David A. Brenner, vice chancellor for Health Sciences and dean of the UCSD School of Medicine.
The three initial two-year projects selected will use UCSD developed molecular technologies to gain understanding of the mechanisms of neuropsychiatric disease and leukemia, with the goal of developing treatments.
“This funding will help provide important new opportunities to translate basic discoveries and leading-edge technologies from UC San Diego’s research laboratories into needed therapies for patients,” said Palmer Taylor, associate vice chancellor for Health Sciences, and dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences.